Attili, I.; Corvaja, C.; Spitaleri, G.; Del Signore, E.; Trillo Aliaga, P.; Passaro, A.; de Marinis, F.
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. Cancers 2023, 15, 5079.
https://doi.org/10.3390/cancers15205079
AMA Style
Attili I, Corvaja C, Spitaleri G, Del Signore E, Trillo Aliaga P, Passaro A, de Marinis F.
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. Cancers. 2023; 15(20):5079.
https://doi.org/10.3390/cancers15205079
Chicago/Turabian Style
Attili, Ilaria, Carla Corvaja, Gianluca Spitaleri, Ester Del Signore, Pamela Trillo Aliaga, Antonio Passaro, and Filippo de Marinis.
2023. "New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations" Cancers 15, no. 20: 5079.
https://doi.org/10.3390/cancers15205079
APA Style
Attili, I., Corvaja, C., Spitaleri, G., Del Signore, E., Trillo Aliaga, P., Passaro, A., & de Marinis, F.
(2023). New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. Cancers, 15(20), 5079.
https://doi.org/10.3390/cancers15205079